Search research articles
Contact Us
Filters
Showing results (261-270 of 317) with videos related to
Page
of 32
Sort By:
Cancer Discovery
|
June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defects
Timothy A Yap, David S P Tan, Anastasios Stathis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 28, 2016
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016
Daniel S W Tan, Sue S Yom, Ming S Tsao, et al.
Cancer
|
September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
Shivaani Kummar, Lin Shen, David S Hong, et al.
ESMO Open
|
June 25, 2023
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group
H H Loong, T Shimizu, A Prawira, et al.
Genome Biology
|
March 29, 2011
Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite
France Denoeud, Michaël Roussel, Benjamin Noel, et al.
Genome Medicine
|
September 24, 2015
Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance
Andre Luiz Vettore, Kalpana Ramnarayanan, Gregory Poore, et al.
Lancet (London, England)
|
January 28, 2017
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Jean-Charles Soria, Daniel S W Tan, Rita Chiari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Daniel S W Tan, Enriqueta Felip, Gilberto de Castro, et al.
Oncotarget
|
November 8, 2017
A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer
Chin-Ann J Ong, Nicholas B Shannon, Stefan Mueller, et al.
Nature Medicine
|
September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Daniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 317) with videos related to
Sort By:
Page
of 32
Cancer Discovery
|
June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defects
Timothy A Yap, David S P Tan, Anastasios Stathis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 28, 2016
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016
Daniel S W Tan, Sue S Yom, Ming S Tsao, et al.
Cancer
|
September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
Shivaani Kummar, Lin Shen, David S Hong, et al.
ESMO Open
|
June 25, 2023
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group
H H Loong, T Shimizu, A Prawira, et al.
Genome Biology
|
March 29, 2011
Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite
France Denoeud, Michaël Roussel, Benjamin Noel, et al.
Genome Medicine
|
September 24, 2015
Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance
Andre Luiz Vettore, Kalpana Ramnarayanan, Gregory Poore, et al.
Lancet (London, England)
|
January 28, 2017
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Jean-Charles Soria, Daniel S W Tan, Rita Chiari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Daniel S W Tan, Enriqueta Felip, Gilberto de Castro, et al.
Oncotarget
|
November 8, 2017
A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer
Chin-Ann J Ong, Nicholas B Shannon, Stefan Mueller, et al.
Nature Medicine
|
September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Daniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.
Page
of 32